Siliq Coupons & Savings Card – Discount Prices from $3260.75

SILIQ is used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy and have not responded or have stopped responding to other systemic therapies.

Yes, SILIQ (brodalumab) is considered an immunosuppressant. It works by inhibiting the activity of interleukin-17, a protein involved in inflammatory and immune responses, which helps reduce inflammation and symptoms in conditions like plaque psoriasis.

The cost of SILIQ can vary depending on factors such as the pharmacy, location, insurance coverage, and any available discounts or patient assistance programs. It is recommended to contact a local pharmacy or healthcare provider for the most accurate and up-to-date pricing information. Additionally, patients may inquire about financial assistance programs offered by the manufacturer to help reduce out-of-pocket costs.

SILIQ (brodalumab) is considered effective for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Clinical trials have shown that a significant number of patients achieve clear or almost clear skin after 12 weeks of treatment. However, the effectiveness can vary among individuals, and it is important for patients to discuss with their healthcare provider to determine if SILIQ is the right treatment option for them.

SILIQ (brodalumab) is not approved for the treatment of psoriatic arthritis. It is approved for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies.